Important Dates:

Registration to open:
25 January 2022

Abstract submission and travel bursary application opens:
25 February 2022

Abstract and travel bursary
closing date:
18 June 2022

Abstract and travel bursary notification:
15 July 2022

Early bird closing date:
15 August 2022

Draft programme outline for 2021 H3D symposium

[pdf-embedder url=”https://h3dsymposium.co.za/wp-content/uploads/2020/05/PROGRAMME-FOR-2021-H3D-SYMPOSIUM_as-at-28-April-2020.pdf” title=”PROGRAMME FOR 2021 H3D SYMPOSIUM_as at 28 April 2020″]

Programme

The Symposium Programme Includes the following Sessions:

  • Global Health Perspectives from Product Development Partnerships
  • Global Health Perspective from Pharmaceutical Companies
  • Global Health Equity and Platform Technologies
  • Neglected Tropical Diseases
  • Malaria
  • Tuberculosis
  • AMR

Programme outline:

DRAFT PROGRAMME FOR 2022 H3D SYMPOSIUM AS AT Mar 2022

Infectious Diseases Drug Discovery in Africa

Tuesday 25 October

14h00 – 17h00

REGISTRATION

THEME

Global Health Perspectives from Product Development Partnerships 15 min talks

17h00 – 17h20

Kelly Chibale (Director, H3D)

Opening Welcome

17h20 – 18h30

Presentations:

Medicines for Malaria Venture (Tim Wells)

GARDP (Manica Balasegaram)

Swiss Embassy (Veronique Haller)

TB Alliance (Nader Fotouhi)

18h30 – 21h00

COCKTAIL FUNCTION

Wednesday 26 October

THEME

Global Health Perspectives 20 min talks

08h30 – 08h50

Speaker 1 – Greg Perry (IFPMA)

08h50 – 09h10

Speaker 2 – Lutz Hegemann (Novartis)

09h10 – 09h30

Industry role in Global Health Partnerships (prelim. title) – Jutta Reinhard-Rupp (Merck Global Health Institute)

09h30 – 09h50

New Drug Discovery approaches for AMR and TB – lessons from Bedaquiline – Anil Koul (JnJ)

09h50 – 10h10

An emerging portfolio in Global Health – Fabian Gusovsky (Eisai)

10h10 – 10h30

Speaker 6 – Juerg Utzinger (STPH)

10h30 – 11h00

TEA / COFFEE BREAK

THEME

Global Health Equity and Platform Technologies 25 min talk 5 min Q

11h00 – 11h30

Global Health Equity – Bernhards Ogutu (KEMRI)

 

11h30 – 12h00

African Drug Metabolism – Mathew Njoroge (Univ. Cape Town)

 

12h00 – 12h30

Ersilia, a hub of open-source AI/ML models for drug discovery and global health – Miguel Duran-Frigola (Ersilia)

 

12h30 – 13h00

AI Speaker 2 – Carolina Horta Andrade (UFG)

 

13h00 – 14h00

LUNCH BREAK

THEME

Neglected Tropical Diseases 25 min talk 5 min Q

14h00 – 14h30

Using basic biological discovery to fuel the pipeline for therapeutics against schistosomes – James Collins (Univ. Texas SWMC)

 

14h30 – 15h00

Recent progress in anthelmintic drug development – Jennifer Keiser (STPH)

 

15h00 – 15h30

Drug Discovery for Neglected Tropical Diseases in the DDU – Ian Gilbert (DDU)

 

15h30 – 15h45

TEA / COFFEE BREAK

15h45 – 16h15

Short Orals 1 & 2, 3 & 4

 

16h15 – 18h00

POSTERS SESSION

19h30 – 21h30

SPEAKERS DINNER – OTHER DELEGATES FREE EVENING

Thursday 27 October

THEME

Malaria Drug Discovery 25 min talk 5 min Q

08h30 – 09h00

Malaria Speaker 1 – Lyn-Marie Birkholtz (Univ. Pretoria)

09h00 – 09h30

Genetic Studies into Plasmodium falciparum determinants of resistance to first-line antimalarial drugs – David Fidock (Columbia Univ.)

 

09h30 – 10h00

Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor – Thomas Spangenberg (Merck)

 

10h00 – 10h30

Malaria Speaker 4 – Elizabeth Winzeler (UCSD)

 

10h30 – 11h00

TEA / COFFEE BREAK

11h00 – 11h30

Malaria Speaker 5 – Rolf Mueller (Helmholtz Institute)

 

11h30 – 12h00

Malaria Speaker 6 – Sergio Wittlin (STPH)

 

12h00  12h30

Malaria Speaker 7 – Philip Rosenthal (Univ. California San Francisco)

 

12h30 – 14h00

PICNIC LUNCH BREAK

THEME

Tuberculosis Drug Discovery 25 min talk 5 min Q

14h00 – 14h30

TB Speaker 1 – Andreas Diacon (Univ. Stellenbosch)

 

14h30 – 15h00

TB Speaker 2 – Mary Jackson (Colorado State Univ.)

 

15h00 – 15h30

TB Speaker 3 – Clif Barry (NIH NIAID)

 

15h30 – 16h00

Next Generation Oxazolidinone Antibiotics for the Treatment of Tuberculosis – Brendan Crowley (Merck)

 

16h00 – 16h15

TEA / COFFEE BREAK

16h15 – 16h45

Re-targeting Gyrase with Spiropyrimidinetriones: The Quest to Overcome Fluoroquinolone Resistance in Tuberculosis – Neil Osheroff (Vanderbilt Univ.)

 

16h45 – 17h15

TB Speaker 6 – Dirk Schnappinger (Weill Cornell)

 

17h15  17h45

TB Speaker 7 – Flavio da Silva Emery (Univ. Sao Paulo)

 

17h45  18h15

TB Speaker 8 – Val Mizrahi (Univ. Cape Town)

 

19h30 – 22h00

CONFERENCE DINNER

Friday 28 October

THEME

Antimicrobial Resistance Drug Discovery 25 min talk 5 min Q

08h30 – 09h00

AMR Speaker 1 – Adrian Brink (Univ. Cape Town)

 

09h00 – 09h30

Target-based anti-infective drug discovery – Anna Hirsch (Helmholtz Institute)

 

09h30 – 10h00

AMR Speaker 3 – Erin Duffy (CARB-X)

 

10h00 – 10h15

Short Oral Slots – 5 & 6

 

10h15 – 10h45

TEA / COFFEE BREAK

10h45 – 11h00

Short Oral Slots – 7 & 8

11h00 – 11h30

 Interkingdom metabolic crosstalk during host-pathogen encounters – Roi Avraham (Weizmann Institute of Science)

11h30 – 12h00

A recent quest to combat AMR: journey from bench to bed – Bala Subramanian (Bugworks)

 

12h00 – 12h15

Short Oral Slots – 9 & 10

 

12h15 – 12h30

Closing remarks Kelly Chibale

 

12h30 – 14h00

LUNCH BREAK & END

Tuesday 25 October 2022

15h00-17h00 : Registration
17h00-18h00 : Welcome and Opening keynote
18h00 – 19h30 : Welcome Cocktail

Wednesday, 26 October 2022

08h30 – 17h00 : Full day conference
19h30 : Speakers dinner
Evening at leisure for other delegates

Thursday, 27 October 2022

08h30 – 17h00 : Full day conference
19h30 : Celebration dinner

Friday, 28 October 2022

08h30 – 12h30 : Half day conference
12h30 – 14h00 : Closing lunch